Triplet Therapy Reduces Risk of Death in Patients With HER-2 Positive Breast Cancer Who Developed Brain Metastases
“This is the first randomized trial to demonstrate an overall survival benefit for patients with brain metastases, which I think is very significant,” said Dr. Nancy U. Lin.
Read More